Our patented biomolecule copier is the basis for all our applications. We use it for the production and replication of all kinds of different microarrays.
BioCopy
We copy your
|
DNA
RNA
PROTEINS
Applications
Our BioCopy patents cover more than 50 different applications. They range from vaccine precursor identification to complex high throughput molecular binding screenings.
Vaccine precursor screening
Vaccines are among the most important medicines of modern times. Here at BioCopy, we are developing a novel approach to significantly reduce the time required to identify vaccine precursors.
Latest News
“Spin-offs To Watch 2021”: Forbes selects BioCopy as one of the 30 particularly most promising spin-offs in the DACH region
In the latest issue of Forbes, BioCopy with its copying and vaccine technology made it to the top 30 university...
Conference on the European healthcare industry in the Covid-19 crisis
BioCopy and CureVac present their contribution to the Covid-19 pandemic to representatives of the European Parliament and the European Commission...
Swiss start-up BioCopy revolutionizes vaccine development
The Swiss journal moneycab published an overview of BioCopy’s innovations in vaccine discovery and diagnostics. Read article (German version only)
Functions like a photocopier
The St. Galler Tagblatt addresses the corona pandemic and clearly shows where there are still gaps in pandemic control and...
BISKUIT: A funded project by the state of Baden-Württemberg, Germany, for rapid identification of COVID19 resistances
BioCopy receives funding from the state of Baden-Württemberg for the development of a rapid Covid 19 test (project BISKUIT) Read...
SARS-Cov2 pandemic: Biocopy characterizes binding sites of neutralizing antibodies
In recent weeks, the BioCopy team has been working hard and applying BioCopy technology to help fight the global Sars...